智通财经APP讯，心泰医疗(02291)发布公告，公司董事会董事长已向董事会提议采纳一项计划(建议H股回购计划)，据此，公司可视乎市况，并不时根据本公司股东于股东大会上批准的回购H股的一般性授权(建议回购授权)，于公开市场回购公司H股。
目前预计根据建议H股回购计划，公司将动用不超过人民币1亿元，于公开市场回购最多550万股H股。
智通财经APP讯，心泰医疗(02291)发布公告，公司董事会董事长已向董事会提议采纳一项计划(建议H股回购计划)，据此，公司可视乎市况，并不时根据本公司股东于股东大会上批准的回购H股的一般性授权(建议回购授权)，于公开市场回购公司H股。
目前预计根据建议H股回购计划，公司将动用不超过人民币1亿元，于公开市场回购最多550万股H股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.